| NCT04677543 | Insmed Incorporated | Mycobacterium Infections, Nontuberculous | 2020-12-22 | PHASE3 |
| NCT07073638 | Thirty Respiratory Limited | Pulmonary Tuberculoses | 2025-10-13 | PHASE2 |
| NCT02409290 | IUATLD, Inc|Medical Research Council|Institute of Tropical Medicine, Belgium|Liverpool School of Tropical Medicine|Rede TB | MDR-TB | 2016-03 | PHASE3 |
| NCT05047055 | Tuberculosis Research Centre, India|Indira Gandhi Government Medical College and Hospital (IGGMCH), Nagpur|King George´s Medical University, Lucknow|Mahavir Hospital and Research Centre, Hyderabad|Government Vellore Medical College and Hospital, Adukkamparai|Lok Nayak hospital, New Delhi | Tuberculosis, Pulmonary | 2022-03-15 | |
| NCT05383742 | National Institute of Allergy and Infectious Diseases (NIAID) | Tuberculous Meningitis | 2023-12-07 | PHASE2 |
| NCT06114628 | University College, London|Radboud University Medical Center|London School of Hygiene and Tropical Medicine|University of Oxford|Research Center Borstel|Lygature|TASK Applied Science|Università Vita-Salute San Raffaele|Helmholtz Zentrum Munchen|KNCV Tuberculosis Foundation|Critical Path Institute|European Lung Foundation|Instituto de Saude Publica da Universidade do Porto|University of Liverpool|Institut de Recherche pour le Developpement|University of Hamburg-Eppendorf|University of California, San Francisco|TB Alliance|Find|University of Milano|University of St Andrews|Uppsala University|European Respiratory Society|Tuberculosis Network European Trialsgroup|Janssen, LP|Otsuka Pharmaceutical Development & Commercialization, Inc.|German Center for Infection Research|Ludwig-Maximilians - University of Munich|University of Cambridge|GlaxoSmithKline | Pulmonary Tuberculosis | 2024-01-09 | PHASE2 |
| NCT00042289 | National Institute of Allergy and Infectious Diseases (NIAID)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | HIV Infections | 2003-06-09 | |
| NCT06905522 | Shenzhen Third People´s Hospital|First Affiliated Hospital of Zhejiang University|Beijing Chest Hospital of Capital Medical University|Shenyang Tenth People´s Hospital|The Sixth People´s Hospital of the Xinjiang Uygur Autonomous Region|The Fourth Hospital of Inner Mongolia Autonomous Region|Guizhou Aerospace Hospital | Pulmonary Tuberculosis | 2025-06-18 | PHASE3 |
| NCT05556746 | Brigham and Women´s Hospital|University of Cape Town|Haitian Group for the Study of Kaposi´s Sarcoma and Opportunistic|University of Stellenbosch|University of California, Los Angeles|Harvard School of Public Health (HSPH) | Tuberculosis, Pulmonary|HIV | 2023-11-24 | PHASE2 |
| NCT00000796 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections|Tuberculosis | | NA |
| NCT07303699 | Obafemi Awolowo University Teaching Hospital|Open Philanthropy|Obafemi Awolowo University | Pulmonary Tuberculosis (TB) | 2026-01-03 | PHASE2 |
| NCT04921943 | Oregon Health and Science University|NTM Info & Research, Inc.|University Health Network, Toronto|New York University | Nontuberculous Mycobacterial Lung Disease|Nontuberculous Mycobacterium Infection | 2021-05-18 | PHASE4 |
| NCT04930744 | University of Massachusetts, Worcester|National Institute of Allergy and Infectious Diseases (NIAID)|Aurum Institute|A*STAR Infectious Diseases Labs|University of Cape Town|Wits Health Consortium (Pty) Ltd | Tuberculosis|Pulmonary Tuberculosis|HIV Coinfection | 2021-08-26 | PHASE2 |
| NCT02554318 | University of Giessen|Indonesian Directorate General of Higher Education | Pulmonary Tuberculosis|Body Weight Changes|Motor Activity | 2013-11 | NA |
| NCT01048697 | Texas Tech University Health Sciences Center|National Center for Research Resources (NCRR)|University of Texas Southwestern Medical Center | Obesity|Tuberculosis | 2010-01 | PHASE4 |
| NCT00000950 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections|Tuberculosis | | NA |
| NCT00001058 | National Institute of Allergy and Infectious Diseases (NIAID) | Mycobacterium Avium-intracellulare Infection|HIV Infections | | PHASE2 |
| NCT05966688 | Spero Therapeutics | Healthy Volunteers | 2023-08-04 | PHASE1 |
| NCT04485156 | Seoul National University Hospital|Chonnam National University Hospital|National Medical Center, Seoul|Pusan National University Hospital|Pusan National University Yangsan Hospital|Seoul National University Bundang Hospital|SMG-SNU Boramae Medical Center|Severance Hospital|Korean Institute of Tuberculosis|International Tuberculosis Research Center|Korean Center for Disease Control and Prevention | Tuberculosis, Pulmonary | 2020-09 | PHASE3 |
| NCT06192160 | National Institute of Allergy and Infectious Diseases (NIAID)|TB Alliance | Pulmonary Tuberculosis | 2025-03-11 | PHASE2 |
| NCT00002101 | Pharmacia | Mycobacterium Avium-Intracellulare Infection|HIV Infections | | PHASE3 |
| NCT04062201 | Wits Health Consortium (Pty) Ltd|Regents of the University of California|University of Cape Town|Perinatal HIV Research Unit of the University of the Witswatersrand | Tuberculosis|Pre-XDR-TB|Extensively Drug-Resistant Tuberculosis|Multi Drug Resistant Tuberculosis|Rifampicin Resistant Tuberculosis | 2019-08-22 | PHASE3 |
| NCT04677569 | Insmed Incorporated | Mycobacterium Infections, Nontuberculous | 2021-04-01 | PHASE3 |
| NCT03672630 | Kevin Winthrop|Patient-Centered Outcomes Research Institute|National Jewish Health|The University of Texas Health Science Center at Tyler|University Health Network, Toronto|New York University|Medical University of South Carolina|Mayo Clinic|Louisiana State University Health Sciences Center in New Orleans|University of California, San Diego|Stanford University|University of Kansas|Vancouver Clinic|University of California, San Francisco|University of Washington|Johns Hopkins University|University of Miami|Emory University|University of Iowa|University of North Carolina|Temple University|Loma Linda University|Columbia University|University of Wisconsin, Madison|Northwell Health|Kaiser Permanente|James A. Haley Veterans Administration Hospital | Mycobacterium Avium Complex|Nontuberculous Mycobacterium Infection | 2019-02-22 | PHASE2|PHASE3 |
| NCT07485010 | The University of Queensland|Innoviva Specialty Therapeutics | Mycobacterium Abscessus Pulmonary Disease|Mycobacterium Abscessus Infection|Non-Tuberculous Mycobacterial (NTM) Infections|Non-Tuberculous Mycobacteria Pulmonary Disease | 2027-04 | PHASE2 |
| NCT04117698 | Assistance Publique - H?pitaux de Paris | Uveitis, Anterior | 2019-11-01 | PHASE3 |
| NCT01601626 | Advancing Clinical Therapeutics Globally for HIV+AIDS and Other Infections|National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infection|Tuberculosis | 2013-07-13 | PHASE2 |
| NCT06253715 | Johns Hopkins University|United States Agency for International Development (USAID) | Tuberculosis|Tuberculosis, Pulmonary|Tuberculosis, Lymph Node|Mycobacterium Tuberculosis | 2025-01-15 | PHASE3 |
| NCT02024555 | Vanderbilt University|National Heart, Lung, and Blood Institute (NHLBI) | Sarcoidosis; Antimycobacterial Therapy | 2014-03 | PHASE2 |
| NCT02193776 | Global Alliance for TB Drug Development | Tuberculosis | 2014-10-23 | PHASE2 |
| NCT02256696 | Johns Hopkins University|University of Cape Town | Pulmonary Tuberculosis | 2015-04-29 | PHASE2 |
| NCT04916899 | Laboratorios Silanes S.A. de C.V. | Tuberculosis | 2014-11 | |
| NCT00351702 | Tuberculosis Research Centre, India|United States Agency for International Development (USAID) | Human Immunodeficiency Virus|Tuberculosis | 2001-02 | PHASE3 |
| NCT04630145 | Janssen Pharmaceutical K.K. | Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) | 2021-01-08 | PHASE2|PHASE3 |
| NCT01589497 | Advancing Clinical Therapeutics Globally for HIV+AIDS and Other Infections|National Institute of Allergy and Infectious Diseases (NIAID) | Tuberculosis | 2015-06-30 | PHASE2 |
| NCT05766267 | Centers for Disease Control and Prevention|Tuberculosis Trials Consortium | Tuberculosis, Pulmonary|Tuberculosis Infection | 2023-11-21 | PHASE2|PHASE3 |
| NCT00001033 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections|Tuberculosis | | PHASE3 |
| NCT00004736 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections|Tuberculosis | | PHASE1 |
| NCT00002331 | Abbott | Mycobacterium Avium-intracellular Infection|HIV Infections | 1994-01 | NA |
| NCT07084402 | Bin Cao|Beijing Chest Hospital, Capital Medical University|Jiangxi Provincial Chest Hospital|MicuRx | Mycobacterium Avium Complex Pulmonary Disease | 2025-07-24 | PHASE4 |
| NCT02581527 | St George´s, University of London|London School of Hygiene and Tropical Medicine|University of Botswana | Pulmonary Tuberculosis | 2017-02-01 | PHASE3 |
| NCT04951986 | University of Cape Town | Disseminated Tuberculosis|HIV | 2021-08-11 | PHASE3 |
| NCT07076225 | Shenzhen Third People´s Hospital|Beijing Chest Hospital, Capital Medical University|Fudan University|West China Hospital|Huazhong University of Science and Technology|Tsinghua University | Pulmonary Tuberculosis | 2025-07-25 | PHASE3 |
| NCT01782950 | Makerere University | AIDS With Tuberculosis | 2013-02 | PHASE4 |
| NCT01785186 | Michael Hoelscher|Sequella, Inc.|European and Developing Countries Clinical Trials Partnership (EDCTP)|German Federal Ministry of Education and Research|Medical Research Council|Radboud University Medical Center | Tuberculosis, Pulmonary | 2013-04 | PHASE2 |
| NCT04310930 | The University of Queensland|Australian Government Department of Health and Ageing|Children´s Hospital Foundation|Cystic Fibrosis Foundation|Newcastle University|Griffith University|Erasmus Medical Center|Monash University|University of Copenhagen|South Australian Health and Medical Research Institute|University of Melbourne|Murdoch Childrens Research Institute|QIMR Berghofer Medical Research Institute | Pulmonary Disease Due to Mycobacteria (Diagnosis) | 2020-03-02 | PHASE2|PHASE3 |
| NCT00367913 | British Thoracic Society | Pulmonary Diseases | 1995-03 | PHASE4 |
| NCT00000641 | National Institute of Allergy and Infectious Diseases (NIAID) | Mycobacterium Avium-intracellulare Infection|HIV Infections | | PHASE2 |
| NCT02563327 | Centers for Disease Control and Prevention|Advancing Clinical Therapeutics Globally for HIV+AIDS and Other Infections | Tuberculosis | 2016-05-30 | PHASE3 |
| NCT00023374 | Centers for Disease Control and Prevention|US Department of Veterans Affairs | Tuberculosis | 2000-08 | NA |
| NCT06081361 | Beijing Chest Hospital|National Medical Center for Infectious Diseases | Pulmonary Tuberculosis|Rifampicin-resistant Tuberculosis | 2023-12-22 | PHASE3 |
| NCT02821832 | National Institute of Allergy and Infectious Diseases (NIAID) | Pulmonary Tuberculosis | 2017-06-21 | PHASE2 |
| NCT01154959 | Tuberculosis Research Centre, India|National Institutes of Health (NIH) | Pulmonary Tuberculosis | 2010-02 | PHASE3 |
| NCT02901288 | Beijing Chest Hospital|Hubei Provincial Center for Disease Control and Prevention|Centre for Tuberculosis Control of Guangdong Province|Hunan Institute For Tuberculosis Control|Anhui Chest Hospital|Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control|Wuhan Institute for Tuberculosis Control|Shanghai Pulmonary Hospital, Shanghai, China|Shenyang Chest Hospital|Changchun Infectious Disease Hospital|First Affiliated Hospital of Xinjiang Medical University|Chengdu Public Health Clinical Center|Taiyuan Fourth People´s Hospital|The Sixth People´s Hospital of Nantong|The Tuberculosis Prevention and Treatment Hospital of Shanxi Province|Beijing Research Institute for Tuberculosis Control|Infectious Disease Prevention Hospital in Heilongjiang Province|The Third People´s Hospital of Zhenjiang|Tianjin centers for Disease Control and Prevention|Harbin Chest Hospital|Chest of Hospital of Xinjiang Uygur Autonomous Region of the PRC|Heilongjiang Province center for tuberculosis Control and Prevention|Tianjin Haihe Hospital|The Infectious Disease Hospital of Wangkai Zaozhuang|The Third People´s Hospital of Kunming City|Kaifeng Central Hospital|The Infectious Hospital of Hebi|Pulmonary Hospital of Lanzhou|The Fourth People´s Hospital of Ningxia Autonomous Region|The Fourth People´s Hospital of Qinghai Province|The Fifth People´s Hospital of Suzhou|Chongqing Infectious Disease Medical Center|Tuberculosis Hospital in Jilin Province|Sixth People´s Hospital of Nanyang City|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Tuberculosis, Pulmonary | 2016-08 | PHASE4 |
| NCT00002343 | Pharmacia | Mycobacterium Avium-Intracellulare Infection|HIV Infections | | PHASE4 |
| NCT07129629 | Shanghai Pulmonary Hospital, Shanghai, China|Huashan Hospital|Guangzhou National Laboratory | Tuberculosis, Pulmonary|Drug-Susceptible Pulmonary Tuberculosis | 2025-08-20 | PHASE2 |
| NCT01994460 | Seoul National University Hospital|Ministry of Health & Welfare, Korea|SMG-SNU Boramae Medical Center|Seoul National University Bundang Hospital|Pfizer | Pulmonary Tuberculosis Without Resistance to Rifampicin | 2014-01 | PHASE2 |
| NCT00002192 | Anderson Clinical Research|Hoechst Marion Roussel | Mycobacterium Avium-Intracellulare Infection|HIV Infections | | PHASE2 |
| NCT05807399 | Michael Hoelscher|Radboud University Medical Center|University of California, San Francisco|University College, London|GlaxoSmithKline|LigaChem Biosciences, Inc. | Pulmonary Tuberculosis|Other Specified Pulmonary Tuberculosis | 2023-04-14 | PHASE2 |
| NCT03474198 | University College, London|National University Hospital, Singapore|Singapore Clinical Research Institute (SCRI) | Tuberculosis, Pulmonary | 2018-03-21 | PHASE2|PHASE3 |
| NCT00001047 | National Institute of Allergy and Infectious Diseases (NIAID) | Mycobacterium Avium-intracellulare Infection|HIV Infections | | PHASE3 |
| NCT02457208 | University of Oxford | Tuberculosis | 2015-07-07 | PHASE1 |
| NCT03236987 | Centre Hospitalier Universitaire, Amiens | Lung Infection|MAC Lung Disease | 2018-02-05 | PHASE3 |
| NCT05454345 | First Affiliated Hospital of Zhejiang University | Tuberculosis, Pulmonary | 2022-10-01 | PHASE3 |
| NCT00864383 | Global Alliance for TB Drug Development|European and Developing Countries Clinical Trials Partnership (EDCTP)|University College, London|Bayer Healthcare Pharmaceuticals, Inc.+Bayer Schering Pharma|Sanofi | Pulmonary Tuberculosis | 2008-01 | PHASE3 |
| NCT07163143 | University College, London|National University of Medical Sciences, Pakistan|Aurum Institute|Biomedical Research and Training Institute, Zimbabwe|Foundation for Innovative New Diagnostics, Switzerland|KTH Royal Institute of Technology|London School of Hygiene and Tropical Medicine|Wits Health Consortium (Pty) Ltd | Tuberculosis (TB) | 2025-11 | PHASE3 |
| NCT00495326 | French National Agency for Research on AIDS and Viral Hepatitis|Medecins Sans Frontieres, Netherlands | Tuberculosis|Aids|Hiv Infections | 2007-12 | PHASE2|PHASE3 |
| NCT00130247 | National Institute of Allergy and Infectious Diseases (NIAID) | Tuberculosis | 2002-04-08 | PHASE3 |
| NCT00002140 | Pfizer | Mycobacterium Avium-intracellulare Infection|HIV Infections | | PHASE3 |
| NCT04504851 | National University Hospital, Singapore | Pulmonary Tuberculosis | 2020-08-12 | PHASE2 |
| NCT00728507 | Johns Hopkins University|Universidade Federal do Rio de Janeiro | Tuberculosis | 2009-11 | PHASE2 |
| NCT06199921 | Obafemi Awolowo University Teaching Hospital|Open Philanthropy | Pulmonary Tuberculosis|Tuberculosis|Koch´s Disease | 2024-01-03 | PHASE2 |
| NCT02372383 | University of Colorado, Denver|Cystic Fibrosis Foundation|Colorado Clinical & Translational Sciences Institute | Cystic Fibrosis | 2014-10 | NA |
| NCT00004689 | National Jewish Health | Mycobacterium Avium-intracellulare Infection | 1991-01 | PHASE2 |
| NCT02057796 | ANRS, Emerging Infectious Diseases | HIV-1 Infection | 2014-09 | PHASE4 |
| NCT02477852 | Beijing Chest Hospital|Beijing Municipal Science & Technology Commission | Tuberculosis, Spinal | 2015-04 | PHASE4 |
| NCT06917495 | Shandong University|Shandong Public Health Clinical Center | Mild Spinal Tuberculosis | 2025-04-05 | PHASE2 |
| NCT00001039 | National Institute of Allergy and Infectious Diseases (NIAID) | Mycobacterium Avium-intracellulare Infection|HIV Infections | | PHASE2 |
| NCT00698334 | All India Institute of Medical Sciences|Ministry of Health & Family Welfare, India | HIV Infections|Acquired Immunodeficiency Syndrome|Tuberculosis | 2006-04 | PHASE3 |
| NCT07213765 | Bin Cao|MicuRx|Shanghai Pulmonary Hospital, Shanghai, China|Beijing Chest Hospital|Anhui Chest Hospital|Jiangxi Chest Hospital|Guangzhou Chest Hospital. | Mycobacterium Avium Complex Pulmonary Disease | 2025-07-24 | PHASE4 |
| NCT02342886 | Global Alliance for TB Drug Development | Tuberculosis, Pulmonary, Drug Sensitive|Tuberculosis, Pulmonary, Multi Drug-resistant | 2015-02 | PHASE3 |
| NCT07058090 | Liaquat National Hospital & Medical College | Drug Induced Liver Injury|Tuberculosis (TB) | 2025-07 | PHASE1 |
| NCT04311502 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV|Tuberculosis | 2021-11-05 | PHASE2 |
| NCT01516203 | National Institute of Allergy and Infectious Diseases (NIAID) | Tuberculosis | 2012-12-05 | PHASE2 |